Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-04
1997-12-30
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548422, A61K 3140
Patent
active
057031118
ABSTRACT:
This invention relates to a stable, easy to constitute, injectable formulation of anticancer agent BMY-25067. More specifically, the present invention concerns a formulation of BMY-25067 obtained from lyophilizing a solution comprising up to 4 mg of BMY-25067 per mL of 65% t-butanol/water, further comprising about 2% PVP (K-12 or K-17), optionally comprising pharmaceutically acceptable carrier(s).
REFERENCES:
patent: 4691023 (1987-09-01), Vyas et al.
patent: 5075454 (1991-12-01), Benigni et al.
Agharkar Shreeram N.
Gogate Uday S.
Phusanti Lawan
Bristol--Myers Squibb Company
DuBoff Samuel J.
Han William T.
Richter Johann
Stockton Laura L.
LandOfFree
Stable injectable formulation of BMY-25067 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable injectable formulation of BMY-25067, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable injectable formulation of BMY-25067 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-202758